Lilly Ventures Fund I Llc - Net Worth and Insider Trading
Lilly Ventures Fund I Llc Net Worth
The estimated net worth of Lilly Ventures Fund I Llc is at least $59 Million dollars as of 2024-05-05. Lilly Ventures Fund I Llc is the 10% Owner of Protagonist Therapeutics Inc and owns about 2,099,482 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $55 Million. Lilly Ventures Fund I Llc is the 10% Owner of Surface Oncology Inc and owns about 3,447,817 shares of Surface Oncology Inc (SURF) stock worth over $4 Million. Lilly Ventures Fund I Llc is also the of Aileron Therapeutics Inc and owns about 54,749 shares of Aileron Therapeutics Inc (ALRN) stock worth over $205,856. Details can be seen in Lilly Ventures Fund I Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lilly Ventures Fund I Llc has not made any transactions after 2018-04-23 and currently still holds the listed stock(s).
Transaction Summary of Lilly Ventures Fund I Llc
Lilly Ventures Fund I Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lilly Ventures Fund I Llc owns 6 companies in total, including Surface Oncology Inc (SURF) , Aileron Therapeutics Inc (ALRN) , and Protagonist Therapeutics Inc (PTGX) among others .
Click here to see the complete history of Lilly Ventures Fund I Llc’s form 4 insider trades.
Insider Ownership Summary of Lilly Ventures Fund I Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SURF | Surface Oncology Inc | 2018-04-23 | 10 percent owner |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 10 percent owner |
| PTGX | Protagonist Therapeutics Inc | 2016-08-16 | 10 percent owner |
 | | 2016-04-06 | 10 percent owner |
| | 2014-11-06 | 10 percent owner |
| | 2014-04-10 | 10 percent owner |
Lilly Ventures Fund I Llc Latest Holdings Summary
Lilly Ventures Fund I Llc currently owns a total of 3 stocks. Among these stocks, Lilly Ventures Fund I Llc owns 2,099,482 shares of Protagonist Therapeutics Inc (PTGX) as of August 16, 2016, with a value of $55 Million and a weighting of 93.36%. Lilly Ventures Fund I Llc owns 3,447,817 shares of Surface Oncology Inc (SURF) as of April 23, 2018, with a value of $4 Million and a weighting of 6.29%. Lilly Ventures Fund I Llc also owns 54,749 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $205,856 and a weighting of 0.35%.
Latest Holdings of Lilly Ventures Fund I Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2016-08-16 | 2,099,482 | 26.09 | 54,775,485 |
| SURF | Surface Oncology Inc | 2018-04-23 | 3,447,817 | 1.07 | 3,689,164 |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 54,749 | 3.76 | 205,856 |
Holding Weightings of Lilly Ventures Fund I Llc
Lilly Ventures Fund I Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Lilly Ventures Fund I Llc has made a total of 0 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years. The most-recent trade in Protagonist Therapeutics Inc is the acquisition of 583,333 shares on August 16, 2016, which cost Lilly Ventures Fund I Llc around $7 Million.
According to the SEC Form 4 filings, Lilly Ventures Fund I Llc has made a total of 0 transactions in Surface Oncology Inc (SURF) over the past 5 years. The most-recent trade in Surface Oncology Inc is the acquisition of 266,000 shares on April 23, 2018, which cost Lilly Ventures Fund I Llc around $4 Million.
According to the SEC Form 4 filings, Lilly Ventures Fund I Llc has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 12,500 shares on July 5, 2017, which cost Lilly Ventures Fund I Llc around $4 Million.
Insider Trading History of Lilly Ventures Fund I Llc
- 1
Lilly Ventures Fund I Llc Trading Performance
GuruFocus tracks the stock performance after each of Lilly Ventures Fund I Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lilly Ventures Fund I Llc is 44.71%. GuruFocus also compares Lilly Ventures Fund I Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lilly Ventures Fund I Llc within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lilly Ventures Fund I Llc's insider trading performs compared to the benchmark.
Performance of Lilly Ventures Fund I Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.53 | | | | | |
| Relative Return to S&P 500(%) | 12.73 | | | | | |
Lilly Ventures Fund I Llc Ownership Network
Lilly Ventures Fund I Llc Owned Company Details
What does Surface Oncology Inc do?
Who are the key executives at Surface Oncology Inc?
Lilly Ventures Fund I Llc is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .
Surface Oncology Inc (SURF) Insider Trades Summary
Over the past 18 months, Lilly Ventures Fund I Llc made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .
In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.
Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Surface Oncology Inc Insider Transactions
Lilly Ventures Fund I Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Lilly Ventures Fund I Llc. You might contact Lilly Ventures Fund I Llc via mailing address: 115 W Washington Street, Suite 1680 South, Indianapolis In 46204.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
